In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of FibroGen Inc (NASDAQ: FGEN) was $1.15 for the day, down -1.71% from the previous closing price of $1.17. In other words, the price has decreased by -$1.71 from its previous closing price. On the day, 1.31 million shares were traded. FGEN stock price reached its highest trading level at $1.18 during the session, while it also had its lowest trading level at $1.05.
Ratios:
Our analysis of FGEN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.33 and its Current Ratio is at 1.52.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on August 08, 2023, Downgraded its rating to Underperform and sets its target price to $2 from $4 previously.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 07 ’24 when Wettig Thane bought 50,000 shares for $1.91 per share. The transaction valued at 95,470 led to the insider holds 470,178 shares of the business.
Henderson Jeffrey William sold 2,000 shares of FGEN for $2,060 on Sep 01 ’23. The Director now owns 28,866 shares after completing the transaction at $1.03 per share. On Aug 04 ’23, another insider, Henderson Jeffrey William, who serves as the Director of the company, sold 2,000 shares for $1.91 each. As a result, the insider received 3,820 and left with 30,866 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FGEN now has a Market Capitalization of 113586880 and an Enterprise Value of 90422936. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.77. Its current Enterprise Value per Revenue stands at 0.612 whereas that against EBITDA is -0.318.
Stock Price History:
Over the past 52 weeks, FGEN has reached a high of $20.73, while it has fallen to a 52-week low of $0.33. The 50-Day Moving Average of the stock is -41.33%, while the 200-Day Moving Average is calculated to be -11.79%.
Shares Statistics:
FGEN traded an average of 2.80M shares per day over the past three months and 1161920 shares per day over the past ten days. A total of 98.77M shares are outstanding, with a floating share count of 91.83M. Insiders hold about 7.02% of the company’s shares, while institutions hold 71.28% stake in the company. Shares short for FGEN as of 1711584000 were 5190713 with a Short Ratio of 1.85, compared to 1709164800 on 6519380. Therefore, it implies a Short% of Shares Outstanding of 5190713 and a Short% of Float of 6.909999999999999.
Earnings Estimates
The stock of FibroGen Inc (FGEN) is currently in the spotlight, with Agenus Inc. analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is $22.99, with high estimates of $20.50 and low estimates of $1.90.
